Literature DB >> 35512008

Epidemiology and molecular characterization of Staphylococcus aureus causing bovine mastitis in water buffaloes from the Hazara division of Khyber Pakhtunkhwa, Pakistan.

Salma Javed1, JoAnn McClure2, Muhammad Ali Syed3, Osahon Obasuyi4, Shahzad Ali5, Sadia Tabassum1, Mohammad Ejaz3, Kunyan Zhang2,4,6,7,8.   

Abstract

Buffalo represent a major source of milk in Pakistan. However, production is impacted by the disease bovine mastitis. Mastitis causes significant economic losses, with Staphylococcus aureus (S. aureus) being one of its major causative agents. While much work has been done understanding the epidemiology of bovine mastitis in Pakistan, detailed molecular characterization of the associated S. aureus is unavailable. In the current study both the epidemiological and molecular characterization of S. aureus from bovine mastitis in the Hazara division of Pakistan are examined. S. aureus was isolated from 18.41% of the animals, and left quarters more prone to infection (69.6%) than right quarters (30.4%). Sub-clinical mastitis (75.31%) was more prevalent than clinical mastitis (24.69%), with infections evenly distributed amongst the eight districts. Molecular characterization revealed that only 19.6% of the isolates were methicillin-resistant, and four strains types identified, including ST9-t7867-MSSA, ST9-MSSA, ST101-t2078-MSSA, and ST22-t8934-MRSA-IVa. Antiseptic resistance genes were not detected in the isolates, and low levels of antibiotic resistance were also noted, however the methicillin-resistant strains had higher overall antibiotic resistance. This study represents the most complete molecular typing data for S. aureus causing bovine mastitis in the Hazara district of Pakistan, and the country as a whole.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35512008      PMCID: PMC9071125          DOI: 10.1371/journal.pone.0268152

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Buffalo are the most frequently reared animals in Asia, estimated to account for 96.78% of the world’s buffalo milk production, at 89.2 million tons [1]. In Pakistan, buffalo produce 68.4% of the country’s milk, however, production is threatened by the infectious disease bovine mastitis [1]. Mastitis in the udders of dairy cattle occurs when pathogenic bacteria enter through the teat canal, where they colonize and multiply in the alveoli. The bacteria produce toxic substances that cause damage to the milk producing tissues, resulting in reduced milk yield and quality [2]. Mastitis can occur in two forms; clinical and subclinical. In clinical mastitis clots and flakes can be seen in the milk and the quarters become swollen, with severe conditions leading to the formation of lacerations, necrosis and cord formation of the teat [3]. In subclinical mastitis (SCLM) no clinical signs or symptoms are apparent, though there is a reduction in milk quantity and quality. Subclinical infection is 15–40 times more prevalent than clinical infection and persists for a long time, rapidly spreading through a herd [4]. Mastitis is one of the leading diseases of the dairy industry, causing economic loss due to low milk yield or quality, loss of lactation, poor animal health, premature culling, and wastage of milk due to over use of antibiotics [5]. Mastitis is two times more prevalent in hand-milked (25.1%) vs machine milked (14.6%) animals [6] and in most developing countries, including Pakistan, dairy animals are milked by hand. Based on mode of transmission and primary reservoir, mastitis pathogens are classified into environmental pathogens that enter into host body from environment and the contagious pathogens are those that transfer from one animal to another. Staphylococcus aureus is a contagious pathogen that efficiently adapts to the environmental conditions of the mammary glands and spreads to and between animals during milking. Infection with S. aureus causes an inflammatory reaction that can result in tissue damage and acute infection can lead to gangrenous mastitis, characterized by blue to black quarters that eventually slough off, often associated with the production of staphylococcal alpha toxin [1]. In Pakistan, S. aureus is one of the most common causative agents of bovine mastitis in buffaloes, accounting for 46.72% of cases [7]. While numerous studies have examined the prevalence and epidemiology of mastitis in various regions of Pakistan, detailed molecular typing of the staphylococci from cases of mastitis in the country is limited [8-11]. The present study, therefore, examines both the epidemiology and molecular characterization of S. aureus from bovine mastitis cases in water buffaloes of different districts of Hazara Division, Khyber Pakhtunkhwa (KP), Pakistan.

Materials and methods

Study area and data collection

The study was conducted in the Hazara Division of KP, Pakistan (August 2019-January 2020). KP is one of the five administrative provinces of Pakistan, located in the North-Western part of the country, across the international border with Afghanistan. The province of Khyber Pakhtunkhwa is divided into 35 districts and seven divisions, with Hazara being one of the seven Divisions, itself containing eight districts; Haripur, Abbottabad, Mansehra, Battagram, Kohistan Upper, Kohistan Lower, Torghar and Kolai Palas. All districts of the Hazara Division were included in the study for sampling. Prior to sampling a questionnaire was designed to collect data about the milking buffaloes and farms from which milk samples were collected. Sampling was done using a three-stage sampling design, as previously described [12]. Eleven buffalo farms were chosen in each district of Hazara Division, randomly selected with the criteria that they be at least 5 km apart (all between 5–10 km) and contain at least 5 animals on the farm. On each farm five buffaloes were conveniently/randomly selected for sampling, for a total of 440 milking water buffaloes (any breed). Both symptomatic (clinical mastitis) and asymptomatic (sub-clinical or uninfected) animals were included in the random sampling. Buffaloes that were not milking, or those with fatal disease, were excluded from the study.

Sampling and initial screening for bovine mastitis

Milk samples were collected from all four teats of each of the 440 buffaloes, with the length of each of the quarters (teat) measured (up to 1mm accuracy) using a ruler, and teat diameter at the apex, midpoint and base measured with a Vernier caliper. Udders were cleaned with 70% ethanol soaked cotton, then the first few drops of milk allowed to flow as waste, followed by the next few drops screened for bovine mastitis using the Surf Field Mastitis test (SFMT) with 4% surf solution (Excel, Uniliver, Pakistan). Positive samples, which formed clots and clumps when mixed with surf solution due to increased somatic cell count (SCC), were collected in a sterile falcon tube (15ml) and labelled. Negative milk samples (milk samples that did not form clots or clumps when mixed with 4% surf excel solution) were discarded immediately after testing. Positive samples were stored on ice until transported to the microbiology lab of the Department of Microbiology (University of Haripur) for further processing.

Culturing of milk samples, S. aureus isolation and susceptibility testing

Milk samples were cultured on mannitol salt agar (MSA) plates, with 50 μl of each sample spread on the plate, and incubated for 24 hours at 37°C. Staphylococci were identified according to standard microbiological procedures, with isolates that were mannitol fermenters, Gram-positive cocci (grape-like clusters), producing catalase, DNase and positive to tube coagulase tests (producing coagulase) with human plasma, considered S. aureus [13]. Further confirmation of S. aureus was done by polymerase chain reaction (PCR) detecting the nuc gene. Antibiotic susceptibility was assessed using standard Clinical and Laboratory Standards Institute guidelines for antimicrobial disk diffusion using the following sixteen antibiotics: ampicillin (AM), amoxicillin (AX), lincomycin (L2), ceftazidime (CAZ), azithromycin (AZM), ceftriaxone (CRO), norfloxacin (NOR), cefoxitin (FOX), gentamicin (CN), erythromycin (E), tetracycline (TE), doxycycline (DO), clindamycin (DA), trimethoprim/sulfamethoxazole (SXT), rifampin (RA), and linezolid (LZN) (Oxoid, UK).

Molecular characterization of the S. aureus isolates

DNA was extracted using the rapid boiling method [14]. A multiplex polymerase chain reaction (PCR) assay, capable of differentiating S. aureus from coagulase negative staphylococci (based on a nuc gene target), while also distinguishing MRSA from MSSA (based on a mecA gene target) and detecting the PVL gene [15], was used to confirm the earlier clinical strain assignation. S. aureus isolates were subsequently fingerprinted using pulsed field gel electrophoresis (PFGE) using a standardized protocol [16]. Briefly, S. aureus agarose plugs were digested with smaI and loaded onto a 1% agarose gel, then electrophoresis done with a CHEF mapper using switch times of 5.3 to 35 sec, for 18 hours at 14°C, 6.0V/cm with an angle of 120 in 0.5x TBE. PFGE-generated DNA fingerprints were analyzed with BioNumerics Ver. 6.6 (Applied Maths, Sint-Martens-Lattem, Belgium) using a position tolerance of 1.5 as well as an optimization of 0 [16]. Strains were assessed for antiseptic resistance (qacA/B, smr) and antibiotic resistance genes (mupA and mupB) with a multiplex PCR assay [17]. Isolates were further characterized with SCCmec typing [18], accessory gene regulator (agr) typing [19], staphylococcal protein A (spa) typing [20], and multilocus sequence typing [21].

Statistical analysis

The collected data was analyzed for the prevalence and association of risk factors with bovine mastitis in different districts of the Hazara Division, as well as for the prevalence of clinical and sub-clinical bovine mastitis. Binary logistic regression was used for two level variable analysis, and multinomial logistic regression used for more than two levels. SPSS was used to determine Chi-Square values for the variables. A p value of <0.05 was considered significant.

Ethics approval

This study was approved by the ethics and research committee of the Department of Zoology, Hazara University, Mansehra, Pakistan (Reference No. hu.zool.rerc321; approval date: May 8, 2019).

Results

Overall epidemiology of Staphylococcus from Hazara division

A total of 440 milking water buffaloes were sampled in the study area, each of which has 4 independent quarters, for a total of 1760 quarters. Of the 440 animals sampled less than half (152; 34.55%) were found to be SFMT positive, indicating the presence of an infection. All the infections contained a bacterial pathogen, as the same percentage of samples (34.55%) resulted in organism growth. As shown in , nearly all of the animals with infections carried staphylococci, found in 140 (31.82%) of them, and S. aureus found in 81 (18.41%) of the animals. Twenty-seven (6.14%) animals were infected by both S. aureus and other coagulase negative staphylococci (CoNS). Only twelve (2.73%) animals were infected solely by non-staphylococcal bacteria. Frequency of bovine mastitis infection at the animal (A) and quarters (B) levels. The number of samples that were SFMT positive, resulted in bacterial growth, contained staphylococci, contained S. aureus, contained S. aureus with coagulase negative staphylococci (CoNS), and only contained other bacteria are indicated above the curve, with corresponding percentages in brackets. Of the 1760 total quarters, 599 (34.03%) were infected and thus SFMT positive, with one fewer (598; 33.98%) resulting in bacterial growth. As seen in , animals were commonly infected by multiple bacterial species, with only 201 (11.42%) of the quarters carrying staphylococci, while 397 (22.56%) of the quarters were infected by other bacteria. S. aureus was isolated from 102 (5.80%) of the quarters, of which 16 (15.69%) were right front quarters (a), 15 (14.71%) were right rear quarters (b), 35 (34.31%) were left front quarters (c), whereas, 36 (35.29%) were left rear quarters (d), as shown in . This indicates that left quarters (69.6%) were more prone to infection than those on the right side (30.4%). Moreover, infection in a single quarter was the most common occurrence, representing 75.31% of the infections, with only 2 animals (2.46%) infected in 3 or more quarters (. Note: No., number of animals; %, percentage. Next we looked at the epidemiology of clinical vs sub-clinical cases of bovine mastitis at the farm, animal and quarter level, and noted that at all levels sub-clinical cases were more common. Of the 440 animals tested, 61 (75.31%) presented with sub-clinical infection, while 20 (24.69%) presented with clinical infection, as summarized in Note: No., number; %, percentage. Finally, the data was broken down into a district-wise analysis, which indicated that there was a widespread and even distribution of infection across the districts, with the exception of Kolai Palas which had fewer cases. Looking specifically at the 102 S. aureus infected animals, we saw an even distribution of cases across the districts, as summarized in and Among the 599 infected quarters, 96 (16.02%) were from animals in Haripur, 69 (11.51%) from Abbottabad, 76 (12.69%) from Mansehra, 72 (12.02%) from Battagram, 89 (14.86%) from Torghar, 92 (15.35%) from Kohistan Upper, 68 (11.35%) from Kohistan Lower, and 37 (6.17%) from Kolai Palas.

Frequency of bovine mastitis, and presence of the S. aureus strain types in each district of the Hazara division.

The Khyber Pakhtunkhwa province is shown shaded grey in the Pakistan map, as is the Hazara division in the KP map. Individual districts in the Hazara division are shown. The upper number in each district is the number of infected quarters (percentage of the 599 total infected quarters), while the lower number is the number of animals infected with S. aureus (percentage of the 81 total S. aureus infected animals). Coloured squares represent the presence of a strain type in the district, with yellow for ST9-MSSA, pink for ST22-t8934-MRSA-IVa, purple for ST101-t2078-MSSA, and blue for ST9-t7867-MSSA. #, number; %, percentage; SA, S. aureus. Note: No., number; %, percentage.

Association between S. aureus infection and the various risk factors associated with mastitis in buffaloes

Various risk factors for bovine mastitis in buffaloes, including breed, age, parity, shelter, milk color, duration of lactation, udder shape, quarter length, quarter shape, quarter lesion, udder condition and treatment, were analyzed to determine if they were associated with infection. As summarized in , breed (p = 0.865), age (p = 0.58), parity (p = 0.923), duration of lactation (p = 0.936), and udder shape (p = 0.553) did not show a statistical association with disease. Shelter, however, was linked to disease (p<0.05), as was milk color (p<0.05) which, with an odds ratio of 33.09 (95% CI, 22.01–35.45), indicated that yellow milk was more linked to mastitis. Quarter length was also associated with disease (p<0.05), as was teat/quarter shape (p<0.05), with cylindrical (OR, 14.3; 95% CI, 14.30–15.65) and round (OR, 20.58; 95% CI, 2.37–178.75) shapes having an increased link to infection. Similarly, udder lesion (88.01, p<0.05), specifically the presence of a laceration (OR, 30.67; 95% CI, 24.25–35.75), is another variable with significantly increased association with infection. Udder condition (p<0.05) was also linked to disease, with the presence of inflammation (OR, 33.59; 95% CI, 1.88–35.11) having a higher odds of disease. Antibiotic treatment is a final variable associated with disease (p<0.05), with no treatment having an increased link to mastitis infection (OR, 9.45; CI, 7.88–11.65). Note: No, Number; %, Percentage; OR, Odd ratio; CI, Confidence Interval. Binary logistic regression was used for two levels and multinomial logistic regression used for more than two levels variables.; χ2 (p-value), Chi-Square value (Pearson values for the variable groups as a whole); *, Significantly associated with the disease (p-value <0.05) †, The variable is continuous therefore the values were calculate for the whole variable.

Molecular epidemiology of S. aureus isolated from buffaloes in Hazara division

The 102 S. aureus isolates were subjected to molecular analysis, with results summarized in , and the full results in S1 Table. Methicillin-resistance levels were low in the region, with 82 (80.4%) of the isolates methicillin-sensitive (MSSA), while only 20 (19.6%) were methicillin-resistant (MRSA). Within the MSSA three spa types were identified, including t2078 (n = 12, 14.6% of the MSSA), t7286 (n = 25, 30.5% of the MSSA), and t7867 (n = 45, 54.9% of the MSSA). The MSSA were all grouped into two MLST and agr types, including ST101-agrI (n = 12, 14.6% of the MSSA) and ST9-agrII (n = 70, 85.4% of the MSSA). In contrast, all of the MRSA shared a single spa (t8834), MLST (ST22) and agr (I) type, and all carried SCCmec type IVa. None of the isolates carried the PVL genes or ACME cassette. Note: No., number; %, percentage; SCCmec, staphylococcal cassette chromosome mec; agr, accessory gene regulator; spa, staphylococcal protein A; ST, Staphylococcal type; qacA/B, multidrug efflux pump; smr, multidrug resistance protein family; mupA/B, mupirocin resistance A/B genes; -, negative *, representing antiseptic resistance genes †, representing antibiotic resistance genes. Based on the PFGE analysis four main strain types were identified in the region, with minor variations of PFGE banding pattern observed within each type (). Twelve isolates belonged to ST9-t7867-MSSA (agrII), sharing 59% or greater similarity in Dice coefficient of correlation (DCC). Fifty-eight isolates belonged to the second group, which shared the same MLST (ST9) as the first group, but occupied to a distinct arm of the dendrogram. This group of ST9-MSSA (agrII) all shared 61% or greater similarity in DCC, but only 50% similarity with the previously first group. Two spa types, t7286 (n = 25) and t7867 (n = 32), were intermixed in this group. The third strain type was ST101-t2078-MSSA (agrI), accounting for 12 of the isolates, all sharing 82% or greater similarity in DCC. The final strain type was ST22-t8934-MRSA-IVa (agrI), representing all 20 of the MRSA, sharing 67% similarity in DCC.

Pulsed field gel electrophoresis fingerprints of all S. aureus isolates from the Hazara district of Pakistan.

Molecular characteristics and corresponding district and farm information are shown. ST9-t7867-MSSA are shaded blue, ST9-MSSA are shaded yellow, ST101-t2078-MSSA are shaded purple, and ST22-t8934-MRSA-IVa are shaded pink. Reference strains types from Canada (CMRSA-) and USA (USA-) are indicated in grey font. mecA, methicillin resistance gene A; mupA, mupirocin resistance gene A; qacAB and smr, efflux mediated antiseptic resistance genes; SCCmec, staphylococcal cassette chromosome mec; ACME, arginine catabolic mobile element; PVL, Panton Valentine Leukocidin; agr, accessory gene regulator; spa, staphylococcal protein A; -, negative for gene; + positive for gene; Ha, Haripur (blue font); Ab, Abbottabad (red font); Ma, Mansehra (orange font); Ba, Battagram (black font); Ku, Kohistan Upper (purple font); Kl, Kohistan Lower (grey font); To, Torghar (green font); KP, Kolai Palas (brown font). In general each strain type was isolated from several districts, and multiple farms in each district, as shown in Figs and . ST9-t7867-MSSA was isolated from 4 of the districts, including Abbottabad, Haripur, Upper Kohistan, and Torghar. The closely related ST9-MSSA was isolated from all 8 districts, while ST101-t2078-MSSA was isolated from 5 districts, including Abbottabad, Upper Kohistan, Torghar, Mansehra and Battagram. Finally, ST22-t8934-MRSA-IVa was isolated from all the districts except upper Kohistan. It is worth noting that 14 of the 17 isolates (representing 12 of 14 animals) from Upper Kohistan belonged to strain type ST9-MSSA, as did 7 of the 10 isolates (representing 5 of 8 animals) from Lower Kohistan. Interestingly, there were ten instances where different strain types were isolated from a single animal, with each strain isolated from different quarters within the animal, and all occuring on different farms. Two animals carried both ST9-t7867-MSSA and ST101-t2078-MSSA, two animals carried both ST9-t7867-MSSA and ST22-t8934-MRSA-IVa, two animals carried both ST9-t7867-MSSA and ST9-MSSA, two animals carried both ST101-t2078-MSSA and ST9-MSSA, and one animal carried both ST22-t8934-MRSA-IVa and ST9-MSSA. One animal also carried two ST9-MSSA belonging to the same PFGE group, but that had different spa types (t7867 and t7286). The presence of antiseptic and antibiotic resistance genes was also assessed by PCR amplification. None of the isolates were positive for the multidrug efflux pump genes (qacA, qacB), small multidrug resistance gene (smr), or mupirocin resistance genes (mupA or mupB).

Antibiotic resistance phenotypes of the S. aureus isolates

Resistance to 16 different antibiotics was assessed in the 102 S. aureus isolates. In general the strains showed low levels of resistance to the antibiotics tested, as shown in . Notable exceptions were ceftazidime, with 100% of the isolates showing resistance, and ampicillin, with 42% of the isolates showing resistance. Approximately 40% of the isolates showed intermediate resistance to cefoxitin and lincomycin, and approximately 57% to ceftriaxone. Note: TMP-SMX, Trimethoprim-sulfamethoxazole. Greater resistance was seen among the ST22-MRSA than amongst the MSSA, with a higher proportion of MRSA resistant to ampicillin (MSSA-29%, MRSA-90%), cefoxitin (MSSA-0%, MRSA-100%), amoxicillin (MSSA-23%, MRSA-55%), doxycycline (MSSA-0%, MRSA-20%), trimethoprim-/sulfamethoxazole (MSSA-8.5%, MRSA-30%), linezolid (MSSA-1.2%, MRSA-10%), azithromycin (MSSA-1.2%, MRSA-25%), ceftriaxone (MSSA-1.2%, MRSA-30%), tetracycline (MSSA-1.2%, MRSA-20%), and erythromycin (MSSA-1.2%, MRSA-10%). There wasn’t a link between antibiotic resistance and the MSSA/MRSA strain type, region or farm from which the samples came (details available in ).

Discussion

Bovine mastitis remains the most prevalent and economically consequential diseases of dairy animals, and Staphylococcus aureus is the most common causative agent. In the current study we characterized staphylococci in lactating buffaloes from the eight districts of Hazara Division, KP, Pakistan. Our study represents the most comprehensive characterization of staphylococcal isolates from cases of bovine mastitis in the region. From an epidemiological standpoint, results from our study were in keeping with previously reported studies on bovine mastitis in Pakistan. We identified mastitis in 34.55% of the animals tested, within the range of prevalence rates previously described in the country. In the Punjab region rates of 44% and 31.75% were found, while in the Faisalabad District rates ranged from 19.74–25.12%, and in the Peshawar District mastitis was found in 36.35% of buffaloes in rural regions [8,9,22,23]. Looking specifically at staphylococci, we isolated the genus from 31.8% of the animals, with S. aureus isolated from 18.41% of the total animals, and 5.8% of the samples (quarters). Our S. aureus prevalence does fall below rates from previous studies where approximately 27% of animals, or 28–50% of samples contained S. aureus [8,9,24,25]. Differential husbandry practices and/or disease management systems between the farms likely contribute to any variations noted. The farms in this study were all private, operating on a very small commercial scale. Cleanliness was being maintained on the farms and infection control practices were followed, however, there were variations in terms of the timing of antibiotic treatment and how strictly isolation and treatment of infected animals was followed. Pakistan is surrounded by tropical and subtropical environments, both of which support the growth of organisms responsible for mastitis [10]. Pathogens can be transmitted by dirty hands, contaminated equipment, soil and insects, therefore differential mitigation of these environmental conditions can adversely affect animal health, and consequently the rates of mastitis seen in the different studies. Also noted in this study was the fact that sub-clinical mastitis infection (75.31%) was more prevalent than was clinical mastitis (24.69%). This is similar to previously reported results such as in the Pothohar region of Punjab, where subclinical mastitis was identified in 67.3% of buffaloes [11], and in the Lahore district where it was identified in 59.64% of buffaloes [23]. Sub-clinical mastitis is a significant concern as no overt symptoms of disease are seen, therefore it can persist undetected for long periods in a herd and spread rapidly between animals. Clinical mastitis, on the other hand, rapidly leads to udder redness, changes in milk condition and sticky discharge, permitting speedy identification and treatment of an infected animal. The consistently high rates of sub-clinical mastitis seen in this and other studies emphasize the importance of adherence to prescribed infection control practices, as well as the need for vigilance and early detection methods. Regular screening for elevated somatic cell count (SCC) would offer the ideal detection system, however it would not be practical for routine use on the farm, therefore alternative screening methods are needed. In our study we noted that factors such as milk color, quarter length, quarter shape and lesion presence, udder condition and antibiotic treatment were all associated with disease. While we saw no association with breed, age, parity, shelter, duration of lactation and udder shape, they too have been associated with disease in other studies [1,10,11,22,26]. Given that regular screening of SCC is not possible on a farm, monitoring for these other associated factors would provide an alternative way to quickly identify sub-clinical infection, and curb its spread. Looking at infections at the quarters level, previous studies have indicated that in buffaloes rear quarters are more prone to infection than front quarter [9,22,23], however, that was not true in our study. We observed that left quarters (both front and rear) had more than twice the infection rate (69.6%) of right quarters (30.4%), which held true in all districts and on all farms. While the rate of infection in the left rear quarter was higher than that in the left front quarter, the left front quarter still had a higher infection rather than the right rear quarter. The reasons why our results differ from previous reports remains unclear, but it likely comes back to milking and infection control practices on the farms. Buffaloes on the farms in this study were all hand milked and it has been reported that in Pakistan milking is primarily done from the left side, meaning the left teats are often being touched while reaching for the right quarters, increasing their chances of contamination [27]. As such, increased attention may need to be paid to sterilization of teats on the milking side in hand milked animals. Cleanliness of the farm would also play a role, as contamination of rear quarters is influenced by their increased exposure to dirt when animals lay on the ground, as well as their increased exposure to urine and fecal material. With cleanliness being well maintained on these smaller farms, the rear quarters would be at a lower risk of infection. The tendency of buffaloes to lay on their left side would also increase exposure of left quarters to injury and infection, increasing their chances of infection. From a molecular standpoint this study presents detailed and important information, since genotyping of S. aureus from Pakistan is not widely done. A thorough understanding of strains affecting both animals and humans in Pakistan is needed to determine if there is widespread transfer from animals to humans, or vice versa, and how it impacts the overall epidemiology of S. aureus in the country. We were unable to find comparable molecular data for strains causing buffalo mastitis, however, in one study that characterized MRSA from table eggs in Haripur two PFGE patterns, representing ST8-t8645-MRSA-IV, ST772-t657-MRSA-IV and ST772-t8645-MRSA-IV were identified [28]. In a study characterizing S. aureus from mastitis in dairy cows in China, isolates belonging to a wide range of clonal complexes (CCs) (15 different CC, encompassing 19 different sequence types) were identified [29]. Several spa types were noted for most of the ST types, and most isolates (93.4%) were methicillin-sensitive. S. aureus from a large variety of CCs were likewise isolated from cow milk samples in other parts of the world, however it is impossible to draw meaningful comparisons as they are in different species or geographical locations [30-34]. In our study 80.4% of the isolates were methicillin sensitive, but differed dramatically from the other studies in that only three ST types were identified. Based on PFGE analysis these were divided into four strain types, including ST9-t7867-MSSA, ST9-MSSA (which clustered apart from the other ST9 in the PFGE dendrogram), ST101-t2078-MSSA and ST22-t8934-MRSA-IVa. This suggests that there is very limited diversity in the S. aureus circulating amongst buffalo farms in this region of Pakistan, which could be due to the close geographic connection between farms and districts in the division, as well as their homogenous climate. With similar environmental factors (such as humidity and temperature) driving selection, similar strain types might prove to be the most fit in each district of this region. Additionally, the farms are small scale and just 5 km apart, meaning the same people could be visiting multiple farms to purchase milk, acting as sources of pathogen transfer. On top of that, the owners of farms in close proximity are often relatives and there can be an exchange of animals between farms, again being a source of pathogen transfer. Comparing the animal associated strains to those in human infections, we observed that our MSSA were different from the human-associated S. aureus identified in Pakistan, while the MRSA were similar to those identified in one investigation. S. aureus in humans (particularly in tertiary care facilities), were primarily identified as CC121-MSSA, ST772-MRSA-V, CC8-MRSA and ST239-MRSA [35-39]. In one study CC22-MRSA-IV was identified in 13.6% (belonging to three different strains) of the human isolates [35], matching the ST type of all the MRSA in our study. As such, it appears that human-associated S. aureus in Pakistan are also limited in diversity and, with one exception, different from the buffalo-associated lineages we identified. Caution must, however, be taken with this conclusion since there are only a few studies available for the country, all with limited sample size, and none within the same geographic location as our study. As well, only one of the studies characterized MSSA, leaving open the possibility that our animal-associated MSSA could yet be identified in humans when a larger number of isolates are tested. In terms of the strains we identified, 68.6% of the isolates belonged to strain type ST9, all being MSSA. ST9 is a predominant livestock-associated S. aureus, particularly in Asian countries like China [40,41] Taiwan [42], and Malaysia [43]. This strain type is frequently detected in pig farms and food products of animal origin, as well found colonizing both animals and human hosts [44], and causing infections in humans [45,46]. Interestingly, ST2454-t7867, a single locus variant of our ST9-t7867, is believed to be commonly associated with bovine mastitis in nearby India [47]. The remainder of the MSSA in this study belonged to strain type ST101, which is encountered in many places across the globe, colonizing and infecting both animals and humans [48-52]. ST101 has also been associated with bulk milk samples and mastitis in cattle [53-55]. All MRSA identified in this study belonged to sequence type ST22, related to the epidemic strain EMRSA-15. This strain is prevalent in both animals (recognized as a causative agent in bovine mastitis) and humans, particularly in Eastern Asia and nearby India where it is believed to be replacing the ST239 clone in hospitals [56-62]. While EMRSA-15 and related ST22 are typically PVL positive, all of our mastitis-associated ST22-MRSA differed in that they were PVL negative, as has been noted for ST22 from tertiary care hospitals in the country [35]. On a final note, our study indicated that there was, in general, a relatively low level of antibiotic resistance amongst the S. aureus isolates. Exceptions were higher levels of resistance to penicillins (ampicillin-42%, amoxacillin 29%), and lincomycin (26.47%). Antibiotic use in food-producing animals is unregulated in Pakistan, with the actual usage unknown. A few studies have looked at commercial farms and determined that antibiotic use in cattle is above international averages, with beta-lactams, aminoglycosides and tetracyclines amongst the classes most commonly chosen [63,64]. Aminopenicillins, in particular, are commonly used for the treatment and prevention of bovine subclinical mastitis, with as high as 36.5% of market milk samples containing beta-lactam residues above the permissible level [65,66]. Unfortunately this study is limited in that the specific antibiotic use for each farm was not documented, therefore cannot be tied directly to the isolates, however future studies could investigate this.

Conclusion

S. aureus remains the primary pathogen of concern in cases of bovine mastitis. This study presents the most complete molecular typing data for both methicillin-sensitive and methicillin-resistant S. aureus causing bovine mastitis in the Hazara district of Pakistan, and the country as a whole. With limited molecular data currently available, our study provides crucial background information for future researchers, and could help elucidate the epidemiological spread of a pathogen that causes significant economic impact on a major industry in the country.

Summary of the Staphylococcus aureus isolated from buffaloes in Hazara division.

(PDF) Click here for additional data file. 1 Mar 2022
PONE-D-22-02764
Epidemiology and Molecular Characterization of Staphylococcus aureus Causing Bovine Mastitis in Water Buffaloes from the Hazara Division of Khyber Pakhtunkhwa, Pakistan
PLOS ONE Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during the review process. Please submit your revised manuscript by Apr 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Herminia de Lencastre, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Javed et al described the epidemiology and the prevalence of staphylococci causing bovine mastitis in water buffaloes in Hazara division of Pakistan. The authors used PFGE to assess the genetic relatedness of the S. aureus isolates recovered in the study and assessed them for antibiotic resistance. The study is well designed and should add to the growing data and knowledge of MRSA in food production animals in the region Below are some comments for consideration Minor comments CoNS was not defined anywhere in the manuscript Except when starting a sentence, “staphylococci” or “staphylococcal” should not be written as “Staphylococci” Authors should consider reviewing the punctuations the manuscript. Major comments The introduction is well written and very easy to read. It gave a detailed background of the study and identified the knowledge gaps this study aimed to fill. I would not want to assume that there is no single study from Pakistan that report the molecular characterization either from human, animals, or environmental matrices. Literature on the population structure of S. aureus should be reviewed and included in this section. The sampling was robust as authors sampled 5 buffaloes in 11 farms from 35 districts but it's not so clear how the farms or the number of buffaloes to be sampled from each farm was determined. If this was a convenience/random sampling, the authors should state this in the manuscript or better still give details on their calculation of the sample size. The authors characterized the S. aureus using PFGE and analyzed the results using BioNumerics with a position tolerance of 1.5 as well as an optimization of 0. Are these parameters previously described? If yes, the author should cite appropriate references and if otherwise, a justification for using these parameters should be stated in the manuscript. The authors described a high prevalence of staphylococci in presumably infected milk samples. How many samples carried both S. aureus and other staphylococci or non-staphylococci. Is there co-occurrence of the bacteria in different samples? If yes, is the co-occurrence specific, common or differ among water buffaloes from different districts? What are the identities of the non-staphylococcal isolates described in this study? As I understood, all the isolates are Gram positive and ferment mannitol as well. The paragraph that addressed molecular characterization in the methods section is quite difficult to follow. The authors should consider splitting this paragraph into two. One for PCR-based and the other for PFGE. In the latter, the authors should consider stating the conditions and other information important for reproducing the results. The authors stated that PCR assay that differentiates S. aureus from coagulase negative staphylococci, while also distinguishing MRSA from MSSA was used. The authors should consider giving a brief detail about this method and the basis for the differentiation, stating the exact gene(s) targeted by the assay. Although one could assume that nuc and mecA genes are targeted but this should be stated in the manuscript. How was the MLST determined? The authors reported that the left quarters were twice prone to infection than those on the right side. Can the comment on this observation and its significance to the study? Again, is this district or farm associated? t8934-ST22-IVa MRSA-IVa was isolated from all the districts except upper Kohistan. What is the prevalence of this clone in health care and community settings in the division studied? Has this clone been reported in animals/livestock or humans in the region? This information is important to contextualize this study. There were also instances of two animals carrying two different clones (ST9-t7867-MSSA and ST101-t2078-MSSA), (ST9-t7867-MSSA and ST22-t8934-MRSA-IVa), (ST9-t7867-MSSA and ST9-MSSA) etc. Are these animals from the same farm? Also, were the two strains recovered from the same quarter? This information is also important. The authors reported that there was no link between antibiotic resistance and the MSSA strain type, region, or farms. Is there a link between antibiotic resistance and MRSA and the farms or regions? In the discussion section, the authors stated that studies on staphylococcal strains causing buffalo mastitis within Pakistan is scarce or not available. Are there studies from other food producing animals on this subject? Also, the authors conclude from their data that there is very limited diversity in S. aureus circulating amongst buffalo farms in this region of Pakistan. Are there animal exchange scenario or workers mobility between the farms studied? This information will be important to further support the conclusion. The authors should consider commenting on how homogenous climate affect the diversity of S. aureus. Reviewer #2: The authors have produced a paper that clearly answers the research question posed. Also, the manuscript was comprehensive and well thought out. This work, on the epidemiology and molecular characterisation of S. aureus in bovine mastitis in Pakistan, is a very interesting addition to the literature where globally mastitis has a significant economic impact. It was also interesting to find that the predominant S. aureus CC, found in water buffalo mastitis, was not CC97 or CC151, the most frequently seen CC in cattle mastitis, but the livestock associated strain, CC9, commonly isolated from pigs in Asia. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Andrew Robb [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 6 Apr 2022 Re: PONE-D-22-02764 Response to reviewers Reviewer #1: Javed et al described the epidemiology and the prevalence of staphylococci causing bovine mastitis in water buffaloes in Hazara division of Pakistan. The authors used PFGE to assess the genetic relatedness of the S. aureus isolates recovered in the study and assessed them for antibiotic resistance. The study is well designed and should add to the growing data and knowledge of MRSA in food production animals in the region Below are some comments for consideration Minor comments CoNS was not defined anywhere in the manuscript -Our apologies, this was a formatting error. The section discussing CoNS was not supposed to be included in the manuscript and failed to get deleted. It has now been removed. Except when starting a sentence, “staphylococci” or “staphylococcal” should not be written as “Staphylococci” -The errors have been corrected. Authors should consider reviewing the punctuations the manuscript. -A review was done and changes made. Major comments 1. The introduction is well written and very easy to read. It gave a detailed background of the study and identified the knowledge gaps this study aimed to fill. I would not want to assume that there is no single study from Pakistan that report the molecular characterization either from human, animals, or environmental matrices. Literature on the population structure of S. aureus should be reviewed and included in this section. -Sorry, you are correct and the sentence was worded poorly. It has been changed to say: “While numerous studies have examined the prevalence and epidemiology of mastitis in various regions of Pakistan, detailed molecular typing of the staphylococci from cases of mastitis in the country is limited.” The population structure of S. aureus in humans in the region is presented (and has been expanded slightly) in the discussion, as it relates to the results. It truly is very limited with a couple studies only going as far as detecting the mecA gene. We feel that adding it to the introduction, specifically at the point where we are presenting the purpose and goals of the paper, would be distracting and dilute out the purpose of the paper. But we agree that the information deserves to be addressed in the paper. 2. The sampling was robust as authors sampled 5 buffaloes in 11 farms from 35 districts but it's not so clear how the farms or the number of buffaloes to be sampled from each farm was determined. If this was a convenience/random sampling, the authors should state this in the manuscript or better still give details on their calculation of the sample size. -The farms were randomly selected with the criteria that they be at least 5 Km apart and contain at least 5 animals. Animals were conveniently/randomly selected for sampling. This has been added to the materials and methods. A reference was included for how sampling (including numbers) was done. 3. The authors characterized the S. aureus using PFGE and analyzed the results using BioNumerics with a position tolerance of 1.5 as well as an optimization of 0. Are these parameters previously described? If yes, the author should cite appropriate references and if otherwise, a justification for using these parameters should be stated in the manuscript. -The reference is the same as the one describing the standardized protocol for PFGE typing S. aureus. A brief description was added to the section. 4. The authors described a high prevalence of staphylococci in presumably infected milk samples. How many samples carried both S. aureus and other staphylococci or non-staphylococci. Is there co-occurrence of the bacteria in different samples? If yes, is the co-occurrence specific, common or differ among water buffaloes from different districts? What are the identities of the non-staphylococcal isolates described in this study? As I understood, all the isolates are Gram positive and ferment mannitol as well. -The number of animals co-infected with SA and CoNS has been added to the manuscript and Figure 1. Co-infection with other species was not specifically tracked since only species that grew on our selective media would be accounted for, creating an inaccurate number. 5. The paragraph that addressed molecular characterization in the methods section is quite difficult to follow. The authors should consider splitting this paragraph into two. One for PCR-based and the other for PFGE. In the latter, the authors should consider stating the conditions and other information important for reproducing the results. -The information was presented in the current order because it provides the easiest workflow for anyone wanting to repeat the experiments. The multiplex PCR is routinely performed first for a quick identification of species and methicillin resistance. PFGE is done next on all S. aureus to identify how many strain types/groups are likely present. Antiseptic resistance PCR, SCCmec typing, agr typing, spa typing and MLST typing are subsequently done for greater detail and strain molecular characterization. Grouping them based on PCR vs PFGE would create a workflow that isn’t ideal. In terms of the PFGE conditions, they are described in the references, however the following information was added: “S. aureus isolates were subsequently fingerprinted using pulsed field gel electrophoresis (PFGE) following digestion by SmaI, using a standardized protocols [11]. Briefly, S. aureus agarose plugs were digested with smaI and loaded onto a 1% agarose gel, then electrophoresis done with a CHEF mapper using switch times of 5.3 to 35 for 18 hours at 14°C, 6.0V/cm with an angle of 120 in 0.5x TBE.” 6. The authors stated that PCR assay that differentiates S. aureus from coagulase negative staphylococci, while also distinguishing MRSA from MSSA was used. The authors should consider giving a brief detail about this method and the basis for the differentiation, stating the exact gene(s) targeted by the assay. Although one could assume that nuc and mecA genes are targeted but this should be stated in the manuscript. How was the MLST determined? -Detailed information is available in the reference however a brief mention of the genes used in the multiplex has been added to the text. We apologize about the MLST omission (formatting error again), the reference was added back. 7. The authors reported that the left quarters were twice prone to infection than those on the right side. Can the comment on this observation and its significance to the study? Again, is this district or farm associated? -The topic was addressed in lines 331-346 of the discussion (original submission), with a slight edit in this version. There is no association between district or farm, which was added to the discussion section. “We observed that left quarters (both front and rear) had more than twice the infection rate (69.6%) of right quarters (30.4%), which held true in all districts and on all farms.” 8. t8934-ST22-IVa MRSA-IVa was isolated from all the districts except upper Kohistan. What is the prevalence of this clone in health care and community settings in the division studied? Has this clone been reported in animals/livestock or humans in the region? This information is important to contextualize this study. -This was addressed in the discussion in lines 369-370 (original submission). With such limited molecular data available for Pakistan, the actual prevalence of ST22-MRSA in health care and community settings is unknown, both for the country as a whole and division studied. There was, likewise, no data from other animals/livestock. “In one study CC22-MRSA-IV was identified in 13.6% (belonging to three different strains) of the human isolates [33], matching the ST type of all the MRSA in our study.” 9. There were also instances of two animals carrying two different clones (ST9-t7867-MSSA and ST101-t2078-MSSA), (ST9-t7867-MSSA and ST22-t8934-MRSA-IVa), (ST9-t7867-MSSA and ST9-MSSA) etc. Are these animals from the same farm? Also, were the two strains recovered from the same quarter? This information is also important. -No they did not occur in the same farm, as previously stated in the results on lines 247-248 (original submission). They were not in the same quarter either, so the sentence has been amended to read: “Interestingly, there were ten instances where different strain types were isolated from a single animal, with each strain isolated from different quarters within the animal, and all occurring on different farms.” 10. The authors reported that there was no link between antibiotic resistance and the MSSA strain type, region, or farms. Is there a link between antibiotic resistance and MRSA and the farms or regions? - We added that MRSA showed no link either. Now read: “There wasn’t a link between antibiotic resistance and the MSSA/MRSA strain type, region or farm from which the samples came (details available in S1 Table).” 11. In the discussion section, the authors stated that studies on staphylococcal strains causing buffalo mastitis within Pakistan is scarce or not available. Are there studies from other food producing animals on this subject? -Unfortunately we found limited studies with detailed molecular data for S. aureus in other food or companion animals. We included what we could find in the discussion. These are examples of the level of detail typically reported in the region. https://doi.org/10.1089/fpd.2018.2585: PFGE but not shown, mecA, mecC, antibiotic resistance in eggs of household chickens. https://doi.org/10.3389/fmicb.2020.577707: detected mecA and spa amplicon size (not sequenced). In chickens, beef, mutton of butcher shops. http://dx.doi.org/10.17582/journal.pjz/2017.49.3.861.867: susceptibility testing. Camels. http://dx.doi.org/10.19045/bspab.2021.100101: mecA PCR. Cats and dogs. 12. Also, the authors conclude from their data that there is very limited diversity in S. aureus circulating amongst buffalo farms in this region of Pakistan. Are there animal exchange scenario or workers mobility between the farms studied? This information will be important to further support the conclusion. The authors should consider commenting on how homogenous climate affect the diversity of S. aureus. -Thank you for this great suggestion. We have add the following information in the: “This suggests that there is very limited diversity in the S. aureus circulating amongst buffalo farms in this region of Pakistan, which could be due to the close geographic connection between farms and districts in the division, as well as their homogenous climate. With similar environmental factors (such as humidity and temperature) driving selection, similar strain types might prove to be the most fit in each district of this region. Additionally, the farms are small scale and just 5 km apart, meaning the same people could be visiting multiple farms to purchase milk, acting as sources of pathogen transfer. On top of that, the owners of farms in close proximity are often relatives and there can be an exchange of animals between farms, again being a source of pathogen transfer.” Reviewer #2: The authors have produced a paper that clearly answers the research question posed. Also, the manuscript was comprehensive and well thought out. This work, on the epidemiology and molecular characterisation of S. aureus in bovine mastitis in Pakistan, is a very interesting addition to the literature where globally mastitis has a significant economic impact. It was also interesting to find that the predominant S. aureus CC, found in water buffalo mastitis, was not CC97 or CC151, the most frequently seen CC in cattle mastitis, but the livestock associated strain, CC9, commonly isolated from pigs in Asia. -Thank you for your appreciation of our manuscript. Submitted filename: Response to reviewers.pdf Click here for additional data file. 20 Apr 2022
PONE-D-22-02764R1
Epidemiology and Molecular Characterization of Staphylococcus aureus Causing Bovine Mastitis in Water Buffaloes from the Hazara Division of Khyber Pakhtunkhwa, Pakistan
PLOS ONE Dear Dr. Zhang Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the additional points raised by reviewer #2.
Please submit your revised manuscript by Jun 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Herminia de Lencastre, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors addressed all the comments and considered all the suggestions. I have no further comments. Reviewer #2: I think that this publication has been well thought out and presented. However, there are a few very minor points. Line 46-47 states "While numerous studies etc". This statement needs to be referenced. Line 86 an should read and. Line 94 gentamycin - spelling is gentamicin. Line 96 Please state the company name of the antibiotic disk supplier. Line 105 Switch times are in seconds. Line 108 The author should differentiate between antiseptic resistance genes (qac) and antibiotic resistance genes (mup). Line 126 34.55% SFMT positive but figure for antimicrobial growth on line 127 states 43.55%. Line 130 the number 27 should be written as Twenty-seven as it begins the sentence line 227-228 Table 5 again the author should differentiate antiseptic and antibiotic resistance genes Line 360 "however, in one study characterized" would read better as "however, in a study that characterized" Line 422 "With limited data currently available, this become crucial background" This sentence is not clear. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
22 Apr 2022 PONE-D-22-02764R1 Response to reviewers Reviewer #1: The authors addressed all the comments and considered all the suggestions. I have no further comments. Reviewer #2: I think that this publication has been well thought out and presented. However, there are a few very minor points. Line 46-47 states "While numerous studies etc". This statement needs to be referenced. -several references added Line 86 an should read and. -thank you, corrected Line 94 gentamycin - spelling is gentamicin. -corrected Line 96 Please state the company name of the antibiotic disk supplier. -added Line 105 Switch times are in seconds. -added Line 108 The author should differentiate between antiseptic resistance genes (qac) and antibiotic resistance genes (mup). -differentiated Line 126 34.55% SFMT positive but figure for antimicrobial growth on line 127 states 43.55%. -Sorry, corrected Line 130 the number 27 should be written as Twenty-seven as it begins the sentence -amended line 227-228 Table 5 again the author should differentiate antiseptic and antibiotic resistance genes -differentiated Line 360 "however, in one study characterized" would read better as "however, in a study that characterized" -sorry, the word was missed during final track change review. Line 422 "With limited data currently available, this become crucial background" This sentence is not clear. -Changed to: “With limited molecular data currently available, our study provides crucial background information for future researchers, and could help elucidate the epidemiological spread of a pathogen that causes significant economic impact on a major industry in the country.” Submitted filename: Response to reviewers 2.pdf Click here for additional data file. 25 Apr 2022 Epidemiology and Molecular Characterization of Staphylococcus aureus Causing Bovine Mastitis in Water Buffaloes from the Hazara Division of Khyber Pakhtunkhwa, Pakistan PONE-D-22-02764R2 Dear Dr. Zhang , We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Herminia de Lencastre, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Dr Andrew Robb 28 Apr 2022 PONE-D-22-02764R2 Epidemiology and Molecular Characterization of Staphylococcus aureus Causing Bovine Mastitis in Water Buffaloes from the Hazara Division of Khyber Pakhtunkhwa, Pakistan Dear Dr. Zhang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Herminia de Lencastre Academic Editor PLOS ONE
Table 1

Summary of the S. aureus positive bovine mastitis infected quarters of buffaloes in Hazara division.

S. aureus positive
No. % X 2 p-value
Right Front Quarter (a)1615.6916.690.000817
Right Rear Quarter (b)1514.71
Left Front Quarter (c)3534.31
Left Rear Quarter (d)3635.29
1 infected quarter6175.31122.95<0.00001
2 infected quarters1923.46
3 infected quarters11.23
4 infected quarters11.23

Note: No., number of animals; %, percentage.

Table 2

Details of clinical and sub-clinical bovine mastitis cases at the farm, animal and quarter level.

LevelOverallOverall MastitisClinical MastitisSub-Clinical Mastitis
No.No.%No.%No.%
Farm886270.452032.265283.87
Animal4408118.412024.696175.31
Quarter17601025.803231.377068.63

Note: No., number; %, percentage.

Table 3

District-wise details of the bovine mastitis clinical and sub-clinical cases in S. aureus infected animals.

District
LevelMastitis Haripur Abbottabad Mansehra Battagram Torghar Kohistan UpperKohistan Lower Kolai Palas
No.%No.%No.%No.%No.%No.%No.%No.%
AnimalOverall1214.811012.351316.051012.351214.811417.2889.8822.47
clinical42031521021031531521015
sub-clinical813.11711.81118.03813.11914.751118.0369.8411.64
QuarterOverall1716.671514.711514.711211.761413.731716.67109.8021.96
clinical825618.7639.3839.38412.5515.6326.2513.13
sub-clinical912.86912.861217.14912.861014.291217.14811.4311.43

Note: No., number; %, percentage.

Table 4

Analysis of the association between animal-level bovine mastitis and its various risk factors.

VariablesBuffaloes95% CI χ2 (p-value)
No. Infected/ total%InfectedOR
BreedNili RaviKhundiAzikheli59/31119/1093/2018.9717.43151.44 (0.90–5.01)1.95 (0.55–6.84)2.28 (0.62–8.34)0.29 (0.865)
Age (Years)234563/96/4444/25526/1112/2133.3313.6417.2523.429.524.92 (0.52–47.07)1.64 (0.55–4.94)1.84 (0.73–4.63)1.74 (0.66–4.62)1.10 (0.45–4.02)2.85 (0.58)
Parity1 time2 times3 times4 times9/4754/30213/695/2219.1517.8818.8422.730.86 (0.26–2.83)0.86 (0.31–2.41)0.72 (0.23–2.22)1.19 (0.56–3.25)0.48 (0.923)
ShelterBarnHouse66/35515/8518.5917.650.38 (0.25–0.40)0.32 (0.16–0.65)416.44 (<0.05)*
Milk colourWhiteYellow64/41217/2815.5360.711.70 (0.99–3.25)33.09 (22.01–35.45)481.29 (<0.05)*
Duration of lactation (months)>0.9–3>3–6>64/204/2573/395201618.480.78 (0.15–3.93)1.09 (0.33–3.57)1.40 (0.44–4.23)0.13 (0.936)
Udder shapeRoundCupBowl44/24825/11612/7617.7421.5515.792.55 (0.95–3.45)0.38 (0.17–0.88)0.97 (0.55–1.71)1.18 (0.553)
Right front quarter length5.0–5.5 cm5.6–6.0 cm6.1–6.5 cm6.6–7.0 cm19/5837/19224/1811/932.7619.2713.2611.114.04 (0.70–23.15)11.56 (<0.05)*
Right rear quarter length5.0–5.5 cm5.6–6.0 cm6.1–6.5 cm6.6–7.0 cm2/250/23216/11413/9210021.5514.0414.130.74 (0.29–1.88) 12.96 (<0.05)*
Left front quarter length5.0–5.5 cm5.6–6.0 cm6.1–6.5 cm6.6–7.0 cm10/3148/23416/1417/3432.2620.5111.3520.5990.18 (0.03–1.15) 9.44 (<0.05)*
Left rear quarter length5.0–5.5 cm5.6–6.0 cm6.1–6.5 cm6.6–7.0 cm7/2816/2145/29913/922576.1915.0514.131.034 (0.32–3.36) 50.86 (<0.05)*
Teat/quarter shapeCylindricalRoundPointedFlat59/3949/248/165/614.9737.55083.3314.30 (14.30–15.65)20.58 (2.37–178.75)1.67 (0.16–17.26)0.71 (0.05–9.70)36.39 (<0.05)*
Teat/quarter lesionNoneLacerationEdema62/42115/154/414.731001002.34 (1.25–4.26)30.67 (24.25–35.75)1.45 (0.27–2.85)88.01 (<0.05)*
Udder conditionNormalInflammationHaemorrhageNecrosisCord formation62/4104/1211/112/32/415.1233.3310066.67501.73 (0.87–3.65)33.59 (1.88–35.11)1.00 (0.25–1.26)1.00 (0.25–1.26)1.00 (0.25–1.26)60.79 (<0.05)*
TreatmentNoneProphylacticPost infection47/32615/9519/1914.4215.791009.45 (7.88–11.65)2.21 (1.74–3.98)1.04 (0.99–1.50)88.10 (<0.05)*

Note: No, Number; %, Percentage; OR, Odd ratio; CI, Confidence Interval. Binary logistic regression was used for two levels and multinomial logistic regression used for more than two levels variables.; χ2 (p-value), Chi-Square value (Pearson values for the variable groups as a whole); *, Significantly associated with the disease (p-value <0.05)

†, The variable is continuous therefore the values were calculate for the whole variable.

Table 5

Overall molecular characteristics of the S. aureus isolated from bovine mastitis cases in the Hazara division.

Molecular Characterization Antiseptic*/Antibiotic Resistance Genes
Isolate No. (%)Type No. (%)No. (%)ST Typespa Typeagr TypeSCCmec Type qacA/B * smr * mupA mupB
S. aureus 102 (50.7%)MSSA 82 (80.4%)12 (14.6%)ST101t2078I-0(0%)0(0%)0(0%)0(0%)
25 (30.5%)ST9t7286II-
45 (54.9)ST9t7867II-
MRSA 20 (19.6%)20 (100%)ST22t8934IIVa

Note: No., number; %, percentage; SCCmec, staphylococcal cassette chromosome mec; agr, accessory gene regulator; spa, staphylococcal protein A; ST, Staphylococcal type; qacA/B, multidrug efflux pump; smr, multidrug resistance protein family; mupA/B, mupirocin resistance A/B genes; -, negative

*, representing antiseptic resistance genes

†, representing antibiotic resistance genes.

Table 6

Antibiotic resistance of the S. aureus from Hazara division.

AntibioticPercentage ResistantPercentage Intermediate ResistancePercentage Sensitive
Ampicillin42.16057.84
Cefoxitin19.6138.2442.16
Clindamycin012.7587.25
Gentamycin1.96098.04
Amoxicillin29.41070.59
Doxycycline2.94097.06
Lincomycin26.4739.2234.31
Ceftazidime10000
Rifampin2.943.9293.14
TMP-SMX12.755.8881.37
Linezolid2.940.0097.06
Azithromycin7.8410.7981.37
Ceftriaxone6.8656.8736.27
Tetracycline5.883.9290.2
Norfloxacin01.9698.04
Erythromycin2.9418.6378.43

Note: TMP-SMX, Trimethoprim-sulfamethoxazole.

  49 in total

1.  Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis.

Authors:  M R Mulvey; L Chui; J Ismail; L Louie; C Murphy; N Chang; M Alfa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Clonality and antimicrobial susceptibility of Staphylococcus aureus and methicillin-resistant S. aureus isolates from food animals and other animals.

Authors:  Pak-Leung Ho; Kin-Hung Chow; Eileen L Lai; Pierra Y T Law; Pui-Ying Chan; Alex Y M Ho; Tak-Keung Ng; Wing-Cheong Yam
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

4.  Prevalent genotypes of meticillin-resistant Staphylococcus aureus: report from Pakistan.

Authors:  A Zafar; M Stone; S Ibrahim; Z Parveen; Z Hasan; E Khan; R Hasan; J Wain; K Bamford
Journal:  J Med Microbiol       Date:  2010-09-30       Impact factor: 2.472

5.  Genotypes and oxacillin resistance of Staphylococcus aureus from chicken and chicken meat in Poland.

Authors:  P Krupa; J Bystroń; J Bania; M Podkowik; J Empel; A Mroczkowska
Journal:  Poult Sci       Date:  2014-10-28       Impact factor: 3.352

Review 6.  Economic effects of bovine mastitis and mastitis management: a review.

Authors:  T Halasa; K Huijps; O Østerås; H Hogeveen
Journal:  Vet Q       Date:  2007-03       Impact factor: 3.320

7.  Evidence of Coxiella burnetii in Punjab province, Pakistan.

Authors:  Muhammad Zubair Shabbir; Sidra Akram; Zia Ul Hassan; Kashif Hanif; Masood Rabbani; Javed Muhammad; Muhammad Hamid Chaudhary; Tariq Abbas; Muhammad Taslim Ghori; Haroon Rashid; Tariq Jamil; Zia-Ul- Islam; Haisem Rasool; Asghari Bano; Arfan Ahmad; Muhammad Asad Ali; Tahir Yaqub; Walt McVey; Bhushan M Jayarao
Journal:  Acta Trop       Date:  2016-07-22       Impact factor: 3.112

8.  Bovine Staphylococcus aureus: Subtyping, evolution, and zoonotic transfer.

Authors:  R Boss; A Cosandey; M Luini; K Artursson; M Bardiau; F Breitenwieser; E Hehenberger; Th Lam; M Mansfeld; A Michel; G Mösslacher; J Naskova; S Nelson; O Podpečan; A Raemy; E Ryan; O Salat; P Zangerl; A Steiner; H U Graber
Journal:  J Dairy Sci       Date:  2015-11-18       Impact factor: 4.034

9.  Longitudinal whole-genome based comparison of carriage and infection associated Staphylococcus aureus in northern Australian dialysis clinics.

Authors:  Deborah C Holt; Tegan M Harris; Jaquelyne T Hughes; Rachael Lilliebridge; David Croker; Sian Graham; Heather Hall; Judith Wilson; Steven Y C Tong; Phillip M Giffard
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

10.  Livestock-associated methicillin-resistant Staphylococcus aureus ST9 in pigs and related personnel in Taiwan.

Authors:  Hsin-Wei Fang; Po-Hsing Chiang; Yhu-Chering Huang
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.